Mega Lifesciences PCL
SET:MEGA
Mega Lifesciences PCL
Common Stock
Mega Lifesciences PCL
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
Common Stock
฿435.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
Common Stock
฿300m
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Mega Lifesciences PCL
Glance View
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
See Also
What is Mega Lifesciences PCL's Common Stock?
Common Stock
435.9m
THB
Based on the financial report for Sep 30, 2025, Mega Lifesciences PCL's Common Stock amounts to 435.9m THB.
What is Mega Lifesciences PCL's Common Stock growth rate?
Common Stock CAGR 10Y
0%
Over the last year, the Common Stock growth was 0%.
